Skip to content

Clinical trials

Mood Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Country / region: Canada Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20053
20072
20115
20123
20131
20154
20161
20184
20192
20201
20212
20221
20233
20243
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting15
Unknown status3
Active, not recruiting2
Terminated2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.4
St. Joseph's Healthcare Hamilton4
Sunnybrook Health Sciences Centre4
Centre for Addiction and Mental Health2
Eli Lilly and Company2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
St. Justine's Hospital2
University Health Network, Toronto2
University of British Columbia2
University of Saskatchewan2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders46
Major Depressive Disorder21
Depressive Disorder13
Mental Disorders13
Anxiety Disorders12
Bipolar Disorder11
Depressive Disorder, Treatment-Resistant5
Alcoholism2
Cognitive Dysfunction2
Conduct Disorder2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.